Holen Sie sich die Stockscreener-App
29.16
0.48%
-0.14
Handel nachbörslich:
29.19
0.03
+0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$29.30
Offen:
$28.79
24-Stunden-Volumen:
564.44K
Relative Volume:
0.50
Marktkapitalisierung:
$1.68B
Einnahmen:
$2.28B
Nettoeinkommen (Verlust:
$-1.13B
KGV:
-1.4683
EPS:
-19.86
Netto-Cashflow:
$35.92M
1W Leistung:
+7.88%
1M Leistung:
+40.87%
6M Leistung:
+32.30%
1J Leistung:
+8.81%
1-Tages-Spanne:
$28.22
$29.31
1-Wochen-Bereich:
$27.46
$30.52
52-Wochen-Spanne:
$19.14
$34.28
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
29.16 | 1.63B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Fortgesetzt | William Blair | Outperform |
| 2026-01-06 | Eingeleitet | BTIG Research | Buy |
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
UBS Adjusts Price Target on Enovis to $51 From $50, Maintains Buy Rating - marketscreener.com
UBS starts medtech coverage, favors Intuitive Surgical and Enovis - Investing.com
ENOV|Enovis Corp|Price:28.260|Chg%:+1.230 - TradingKey
Enovis Corp (ENOV) Income Statement - TradingKey
Enovis Corp (ENOV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enovis Corp (ENOV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Enovis Corp (ENOV) Balance Sheet - TradingKey
Enovis Corp (ENOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ENOV|Enovis Corp|Price:29.621|Chg%:+1.371 - TradingKey
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout | AI
ENOV|Enovis Corp|Price:27.030|Chg%:+0.990 - TradingKey
Enovis Corporation (ENOV) Stock Forecasts - Yahoo Finance
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis - MSN
Enovis Corporation (ENOV) Stock Analysis: A 51.74% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Enovis (ENOV) 43rd Annual J.P. Morgan Healthcare Conference 2025 Summary - Quartr
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis stocks trade down, what you need to know - MSN
Is Enovis (ENOV) Undervalued On Its CT RevitL Launch Or Is That Priced In? - simplywall.st
Enovis Corp (ENOV) Shares Fall 3.6% -- What GF Score of 64 Tells Investors - GuruFocus
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know - Yahoo Finance
Is Enovis (ENOV) Using CT-RevitL to Quietly Redefine Its Veterinary Innovation Strategy? - simplywall.st
CFX5924786 Bond Profile — Key Metrics - TradingView
US194014AB2 Bond Profile — Key Metrics - TradingView
Enovis (ENOV) stock trades up, here is why - MSN
Enovis to host Q2 2026 results conference call on August 6 - scanx.trade
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th - The Manila Times
Enovis Corporation to Host Second Quarter 2026 Investor Conference Call and Webcast on August 6 - Quiver Quantitative
Enovis will webcast its second-quarter results on Aug. 6 - Stock Titan
Enovis Corp (ENOV) Shares Surge 3.8% -- What GF Score of 60 Tells Investors - GuruFocus
Enovis Corporation (ENOV) Surges 4.36% as It Approaches Resistance LevelTurnaround Stocks - dars.gov.et
Enovis (ENOV) Receives a Buy from Jefferies - The Globe and Mail
Jefferies Initiates Enovis Corp(ENOV.US) With Buy Rating, Announces Target Price $40 - Moomoo
Enovis (ENOV) Stock Trades Up, Here Is Why - Yahoo Finance
Enovis Launches New Veterinary Laser Therapy System in the U.S. - Vet Candy
Enovis launches veterinary laser therapy system in U.S. - Investing.com
Enovis launches veterinary laser therapy system in U.S. By Investing.com - Investing.com Canada
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care - The Manila Times
Enovis™ Companion Animal Health Launches CT-RevitL™, the - GlobeNewswire
CD&R Engages Former Enovis CEO as Operating Advisor - AOL.com
BMO Capital Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $29 - 富途牛牛
BMO Capital Initiates Enovis at Outperform With $29 Price Target - marketscreener.com
Does Enovis (ENOV) Leaving Russell Defensive Indexes Signal A Deeper Shift In Its Risk Profile? - simplywall.st
Enovis (ENOV) Coverage Started with Outperform Rating and $29 Ta - GuruFocus
American Century affiliates report 10.6% holdings in Enovis (ENOV) - Stock Titan
Enovis (ENOV) Following CMS Reversal, Why The Valuation Story Is Back In Focus - simplywall.st
Why Enovis (ENOV) Stock Is Trading Up Today - Yahoo Finance
Enovis shares jump after Medicare reverses reimbursement cuts By Investing.com - Investing.com Nigeria
Enovis shares jump after Medicare reverses reimbursement cuts - Investing.com
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Enovis Corp-Aktie (ENOV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Engert Oliver | Chief Administrative Officer |
Jun 11 '26 |
Buy |
21.62 |
1,200 |
25,948 |
51,840 |
| Engert Oliver | Chief Administrative Officer |
Jun 10 '26 |
Buy |
23.00 |
1,000 |
23,000 |
50,640 |
| Engert Oliver | Chief Administrative Officer |
Jun 01 '26 |
Buy |
22.22 |
1,000 |
22,220 |
49,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 13 '26 |
Buy |
23.74 |
1,000 |
23,740 |
48,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 10 '26 |
Buy |
23.93 |
1,000 |
23,930 |
47,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 09 '26 |
Buy |
23.39 |
1,000 |
23,390 |
46,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 06 '26 |
Buy |
24.41 |
750 |
18,310 |
45,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 03 '26 |
Buy |
24.77 |
1,000 |
24,770 |
44,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 04 '26 |
Buy |
25.10 |
250 |
6,275 |
44,890 |
| Engert Oliver | Chief Administrative Officer |
Feb 27 '26 |
Buy |
25.50 |
1,000 |
25,500 |
43,640 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):